BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 29502188)

  • 1. Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.
    Creux H; Monnier P; Son WY; Buckett W
    J Assist Reprod Genet; 2018 Apr; 35(4):583-592. PubMed ID: 29502188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elective and Onco-fertility preservation: factors related to IVF outcomes.
    Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
    Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the scope of in vitro maturation for fertility preservation: transvaginal retrieval of immature oocytes during endoscopic gynaecological procedures.
    Song XL; Lu CL; Zheng XY; Nisenblat V; Zhen XM; Yang R; Li M; Li R; Yuan YF; Ma CH; Liu P; Feng HL; Yan J; Qiao J
    Hum Reprod; 2020 Apr; 35(4):837-846. PubMed ID: 32154563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IVF versus ICSI for the fertilization of in-vitro matured human oocytes.
    Walls M; Junk S; Ryan JP; Hart R
    Reprod Biomed Online; 2012 Dec; 25(6):603-7. PubMed ID: 23063820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience.
    Mayeur A; Puy V; Windal V; Hesters L; Gallot V; Benoit A; Grynberg M; Sonigo C; Frydman N
    J Assist Reprod Genet; 2021 Jul; 38(7):1767-1775. PubMed ID: 33797007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
    Creux H; Monnier P; Son WY; Tulandi T; Buckett W
    Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparision of in vitro maturation applied in PCOS and non-PCOS patients undergo stimulated and unstimulated protocols].
    Wang P; Zhao J; Jin C; Yu R; Lin J; Zhu R; Wu Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):903-8. PubMed ID: 25608990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
    Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
    Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added Benefit of Immature Oocyte Maturation for Fertility Preservation in Women with Malignancy.
    Cohen Y; Tannus S; Volodarsky-Perel A; Son WY; Tulandi T; Buckett W
    Reprod Sci; 2020 Dec; 27(12):2257-2264. PubMed ID: 32617879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience.
    Cardozo ER; Thomson AP; Karmon AE; Dickinson KA; Wright DL; Sabatini ME
    J Assist Reprod Genet; 2015 Apr; 32(4):587-96. PubMed ID: 25595540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue in vitro maturation (IVM) of immature oocytes in stimulated cycles in women with low functional ovarian reserve (LFOR).
    Lee HJ; Barad DH; Kushnir VA; Shohat-Tal A; Lazzaroni-Tealdi E; Wu YG; Gleicher N
    Endocrine; 2016 Apr; 52(1):165-71. PubMed ID: 26419849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
    Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
    Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles.
    Gremeau AS; Andreadis N; Fatum M; Craig J; Turner K; McVeigh E; Child T
    Fertil Steril; 2012 Aug; 98(2):355-60. PubMed ID: 22658347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
    Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A "freeze-all" embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome?
    Ortega-Hrepich C; Stoop D; Guzmán L; Van Landuyt L; Tournaye H; Smitz J; De Vos M
    Fertil Steril; 2013 Oct; 100(4):1002-7. PubMed ID: 23850301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes.
    Segers I; Bardhi E; Mateizel I; Van Moer E; Schots R; Verheyen G; Tournaye H; De Vos M
    Hum Reprod; 2020 Sep; 35(9):2026-2036. PubMed ID: 32829388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy.
    Das M; Shehata F; Son WY; Tulandi T; Holzer H
    Hum Reprod; 2012 Aug; 27(8):2509-14. PubMed ID: 22617122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
    Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.